AstraZeneca has scope to increase dividend by 25%, key broker says, as broader FTSE 100 edges lower

Anglo-Swedish pharmaceutical AstraZeneca has scope to increase its dividend by 25%, a key broker said on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.